Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Ideaya Biosciences Inc shares valued at $1,032,884 were sold by WHITE MICHAEL ANTHONY on May 29 ’24. At $36.24 per share, WHITE MICHAEL ANTHONY sold 28,500 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Hata Yujiro S sold 34,433 shares, netting a total of over 1,439,754 in proceeds. Following the sale of shares at $41.81 each, the insider now holds 677,887 shares.
Before that, Hata Yujiro S had sold 83,856 shares from its account. In a trade valued at $3,597,756, the President and CEO traded Ideaya Biosciences Inc shares for $42.90 each. Upon closing the transaction, the insider’s holdings decreased to 83,856 shares, worth approximately $23.3 million.
As published in their initiating research note from BTIG Research on March 08, 2024, Ideaya Biosciences Inc [IDYA] has been a Buy and the price target has been revised to $55. Analysts at SVB Securities started covering the stock with ‘”an Outperform”‘ outlook in a report released in early August. As of May 24, 2023, Goldman has initiated its “Buy” rating for IDYA. Earlier on April 24, 2023, Stifel upgraded its rating. Their new recommendation was “a Buy” for IDYA stock which previously was a “a Hold”.
Analyzing IDYA Stock Performance
During the last five days, there has been a drop of approximately -5.24%. Over the course of the year, Ideaya Biosciences Inc shares have dropped approximately -3.40%. Shares of the company reached a 52-week high of $47.74 on 02/15/24 and a 52-week low of $33.46 on 01/05/24. A 50-day SMA is recorded $39.10, while a 200-day SMA reached $36.78. Nevertheless, trading volume fell to 0.83 million shares from 0.84 million shares the previous day.
Support And Resistance Levels for Ideaya Biosciences Inc (IDYA)
According to the 24-hour chart, there is a support level at 34.01, which, if violated, would cause prices to drop to 33.65. In the upper region, resistance lies at 34.91. The next price resistance is at 35.45. RSI (Relative Strength Index) is 33.00 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -2.08, which suggests the price will decrease in the coming days. Percent R is at 97.21%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
